Telix Pharmaceuticals Limited (ASX: TLX)
Australia
· Delayed Price · Currency is AUD 24.74
-0.93 (-3.62%)
Dec 20, 2024, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 8.28 billion as of December 20, 2024. Its market cap has increased by 172.36% in one year.
Market Cap
8.28B
Enterprise Value
8.18B
Revenue
645.68M
Ranking
n/a
PE Ratio
168.20
Stock Price
24.74
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 8.28B, an increase of 5,346.45%. That is a compound annual growth rate of 75.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 133.92B |
| ResMed Inc. | 55.68B |
| Pro Medicus Limited | 25.98B |
| Fisher & Paykel Healthcare Corporation Limited | 20.11B |
| Cochlear Limited | 18.92B |
| Sonic Healthcare Limited | 13.05B |
| Ramsay Health Care Limited | 7.89B |
| Neuren Pharmaceuticals Limited | 1.55B |